Biogen stock up as sales of Leqembi beat expectations
Biogen's Leqembi, the first drug to slow the progression of Alzheimer's, launched last year
Source: qz.com
Japan Based Eisai News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Japan Based Eisai. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Japan Based Eisai Today - Breaking & Trending Today
Are we FINALLY close to solving the Alzheimer's puzzle?
Patients in the UK must undergo a swathe of tests, including scans and a lumbar puncture, with some facing waits of up to four years for their Alzheimer's diagnosis.
Source: dailymail.co.uk
Alzheimer's Drug Meant To Slow Disease Becomes More Accessible to Americans After Getting FDA's Full Approval | HNGN
The FDA approved Leqembi for people with early Alzheimer's disease on Thursday, making it easier for older adults to obtain the first drug to slow memory and thinking issues.
Source: hngn.com
Eisai and Biogen Alzheimer's drug lecanemab receives approval from FDA
Eisai and Biogen's drug, sold under the brand name Leqembi, is the first amyloid-targeting medication to pass the FDA's full review.
Source: phillyburbs.com
Eisai and Biogen Alzheimer's drug lecanemab receives approval from FDA
Eisai and Biogen's drug, sold under the brand name Leqembi, is the first amyloid-targeting medication to pass the FDA's full review.
Source: usatoday.com